title: [Clinical and immunological profile of HIV-infected patients at the initiation of antiretroviral therapy in Douala].
abstract: The aim of this study was to describe the clinical and immunological profile of patients infected with HIV after initiation of antiretroviral therapy. Sociodemographic characteristics, clinical and immunological patients were recorded. Chi square test and Mann-Whitney were used to compare variables. The multivariate regression model identified risk factors. So that, 936 (56.2%) patients were in stages III and IV of the WHO and 65.2% at an advanced stage of the disease. Factors associated with initiation at an advanced stage, were male sex (p = 0.007) and time to diagnosis (p = 0.005). In 2/3 cases, treatment is started at an advanced stage of disease. It is therefore important to intensify awareness campaigns for early detection and encourage patients to ensure regular medical follow-up screening.
authors: Faculté de médecine et des sciences pharmaceutiques, BP 15253, Douala, Cameroun. noelesso@yahoo.fr.|Comité national de lutte contre le sida du Cameroun, Douala, Cameroun. noelesso@yahoo.fr.
authors: N E
authors: NE
authors: Essomba
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.|Faculté de médecine et des sciences pharmaceutiques, BP 15253, Douala, Cameroun.
authors: B H
authors: BH
authors: Mbatchou Ngahane
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.|Faculté de médecine et des sciences pharmaceutiques, BP 15253, Douala, Cameroun.
authors: M
authors: M
authors: Nida
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.
authors: E
authors: E
authors: Temfack
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.|Faculté de médecine et des sciences pharmaceutiques, BP 15253, Douala, Cameroun.
authors: Y
authors: Y
authors: Mapoure Njankouo
authors: Faculté de médecine et des sciences pharmaceutiques, BP 15253, Douala, Cameroun.
authors: R L
authors: RL
authors: Abeng
authors: Faculté de médecine et des sciences pharmaceutiques, BP 15253, Douala, Cameroun.
authors: Z Kobe
authors: ZK
authors: Fokalbo
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.
authors: H
authors: H
authors: Achu Joko
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.|Faculté de médecine et des sciences pharmaceutiques, BP 15253, Douala, Cameroun.
authors: M
authors: M
authors: Mbenoun
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.|Faculté de médecine et des sciences pharmaceutiques, BP 15253, Douala, Cameroun.
authors: A P
authors: AP
authors: Meledie
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.|Faculté de médecine et des sciences pharmaceutiques, BP 15253, Douala, Cameroun.
authors: M P
authors: MP
authors: Halle
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.
authors: A
authors: A
authors: Malongue
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.
authors: C
authors: C
authors: Tchente
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.
authors: T
authors: T
authors: Nana Njamen
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.
authors: G
authors: G
authors: Halle Ekane
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.
authors: S
authors: S
authors: Ngwane
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.
authors: E
authors: E
authors: Barla
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.
authors: P
authors: P
authors: Abena
authors: Hôpital de District de Bonassama, Douala, Cameroun.
authors: P
authors: P
authors: Ndobo
authors: Hôpital de District de Nylon, Douala, Cameroun.
authors: C
authors: C
authors: Moungo Kuidjeu
authors: Faculté de médecine et des sciences pharmaceutiques, BP 15253, Douala, Cameroun.
authors: D
authors: D
authors: Adiogo
authors: Faculté de médecine et des sciences pharmaceutiques, BP 15253, Douala, Cameroun.
authors: A
authors: A
authors: Mouelle Sone
authors: Centre de traitement agréé de l'Hôpital général de Douala, Douala, Cameroun.
authors: H
authors: H
authors: Luma Namme
authors: École de santé publique, Université libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgique.
authors: Y
authors: Y
authors: Coppieters
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002163:Cameroon / Q000453:epidemiology; D003430:Cross-Sectional Studies; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology* / Q000276:immunology*; D015497:HIV-1; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents
keywords: Bioclinical profile; Cameroon; District Hospital of Bonassama; District Hospital of Nylon; General hospital of Douala; Initiation of antiretroviral therapy; PLHIV; Sub-Saharan Africa